Financial reports
10-K
2009 FY
Annual report
28 Oct 09
10-Q
2009 Q3
Quarterly report
15 Jul 09
10-K/A
2008 FY
Annual report (amended)
20 Apr 09
10-Q
2009 Q2
Quarterly report
13 Apr 09
10-Q
2009 Q1
Quarterly report
13 Jan 09
10-K/A
2008 FY
Annual report (amended)
23 Dec 08
10-K
2008 FY
Annual report
30 Oct 08
10QSB
2008 Q3
Quarterly report (small business)
9 Jul 08
Current reports
8-K
Raptor Pharmaceuticals and TorreyPines Therapeutics Receive
6 Oct 09
8-K
2009 Annual Meeting of Stockholders
31 Aug 09
8-K
Entry into a Material Definitive Agreement
25 Aug 09
8-K
Entry into a Material Definitive Agreement
31 Jul 09
8-K
Entry into a Material Definitive Agreement
28 Jul 09
8-K
Regulation FD Disclosure
24 Jul 09
8-K
Regulation FD Disclosure
23 Jun 09
8-K
Entry into a Material Definitive Agreement
9 Jun 09
8-K
Other Events
1 May 09
8-K
Entry into a Material Definitive Agreement
14 Apr 09
Registration and prospectus
15-12G
Securities registration termination
30 Sep 09
POS AM
Prospectus update (post-effective amendment)
30 Sep 09
S-8 POS
Registration of securities for employees (post-effective amendment)
30 Sep 09
D
$2.39M in equity / options, sold $2.39M, 4 investors
16 Sep 09
425
Business combination disclosure
31 Aug 09
425
Business combination disclosure
25 Aug 09
425
Business combination disclosure
25 Aug 09
424B3
Prospectus supplement
31 Jul 09
424B3
Prospectus supplement
23 Jul 09
424B3
Prospectus supplement
23 Jun 09
Other
CT ORDER
Confidential treatment order
5 Jan 10
EFFECT
Notice of effectiveness
1 Oct 09
UPLOAD
Letter from SEC
27 Apr 09
CORRESP
Correspondence with SEC
9 Apr 09
CORRESP
Correspondence with SEC
25 Mar 09
UPLOAD
Letter from SEC
13 Mar 09
EFFECT
Notice of effectiveness
11 Dec 08
EFFECT
Notice of effectiveness
5 Aug 08
CT ORDER
Confidential treatment order
16 Jun 08
EFFECT
Notice of effectiveness
10 Jul 06